Johnson & Johnson Vows to Fight $55 Million Talcum Powder Loss

Johnson & Johnson (NYSE:JNJ) vowed to fight the $55 million loss a Missouri jury handed it this week after finding for a woman who said that using its talc-powder products for feminine hygiene caused her to develop ovarian cancer.

It’s the 2nd verdict to go against the New Brunswick, N.J. healthcare giant, after another Show Me State jury ordered J&J to pay $72 million to the family of a woman whose death from ovarian cancer was linked to her use of its talc-based Baby Powder and Shower to Shower for several decades.

Johnson & Johnson faces roughly 1,200 lawsuits accusing it of not adequately warning consumers about the talc-based products’ cancer risks.

Back to news